Anakinra
Common brands: Kineret, Methotrexate, Rasuvo, Otrexup, Trexall
Top reporter: Swedish Orphan Biovitrum Ab (Publ)
Interleukin-1 Receptor Antagonist [EPC]Corticosteroid [EPC]Tumor Necrosis Factor Blocker [EPC]Folate Analog Metabolic Inhibitor [EPC]Interleukin-6 Receptor Antagonist [EPC]
16,150
Total Reports
4,556
Serious Reports
1,476
Death Reports
30
Reported Reactions
Death Report Ratio: High (9.14%)
Patient Demographics
Reported Adverse Reactions (30)
Side effects reported in FDA adverse event reports for Anakinra.
| # | Reaction | Reports | % of Total |
|---|---|---|---|
| 1 | OFF LABEL USE | 5,068 | |
| 2 | DRUG INEFFECTIVE | 4,184 | |
| 3 | CONDITION AGGRAVATED | 1,652 | |
| 4 | PAIN | 1,569 | |
| 5 | RHEUMATOID ARTHRITIS | 1,542 | |
| 6 | JOINT SWELLING | 1,187 | |
| 7 | ARTHRALGIA | 1,183 | |
| 8 | DRUG INTOLERANCE | 1,164 | |
| 9 | PYREXIA | 1,138 | |
| 10 | INJECTION SITE PAIN | 1,005 | |
| 11 | RASH | 966 | |
| 12 | NAUSEA | 945 | |
| 13 | PRODUCT DOSE OMISSION ISSUE | 896 | |
| 14 | INFECTION | 893 | |
| 15 | DRUG HYPERSENSITIVITY | 866 | |
| 16 | VOMITING | 865 | |
| 17 | DIARRHOEA | 862 | |
| 18 | CONTRAINDICATED PRODUCT ADMINISTERED | 841 | |
| 19 | SYNOVITIS | 800 | |
| 20 | FATIGUE | 757 | |
| 21 | ARTHROPATHY | 725 | |
| 22 | INJECTION SITE ERYTHEMA | 711 | |
| 23 | ARTHRITIS | 690 | |
| 24 | TREATMENT FAILURE | 681 | |
| 25 | MALAISE | 678 | |
| 26 | THERAPEUTIC PRODUCT EFFECT DECREASED | 673 | |
| 27 | MOBILITY DECREASED | 664 | |
| 28 | C-REACTIVE PROTEIN INCREASED | 640 | |
| 29 | RED BLOOD CELL SEDIMENTATION RATE INCREASED | 634 | |
| 30 | SEPTIC SHOCK | 603 |
Important Disclaimer
FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.